Enrollment complete in Dune Medical Devices' MarginProbe pivotal clinical trial

[News]

Dune Medical Devices today announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast. The randomized, controlled trial includes 664 women who underwent BCS at one of 21 leading medical facilities, with 18 in the US and three in Israel.

More... (http://www.news-medical.net/news/20100112/Enrollment-complete-in-Dune-Medical-Devices-MarginProbe-pivotal-clinical-trial.aspx)